Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions
- PMID: 312169
- PMCID: PMC1537637
Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions
Abstract
C. parvum and BCG produced significant changes in NK, K and T cell lymphocytotoxicity using a Chang liver target cell. A consistent temporal pattern over 28 days of early depression, recovery, overshoot and then decline was described. This was particularly marked for C. parvum and 'K' cell activity. Skin test reactivity to recall antigens at 28 days was not appreciably different from the pre-immunization reactivity. The importance of using lymphocyte concentration-cytotoxicity titration curves and the linearization of such curves is discussed. An immunotherapy schedule with 3 weekly immunization intervals is proposed as the optimum schedule in patients receiving C. parvum at a dose of 2.0 mg/m2 i.v.
Similar articles
-
Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity reactions.Clin Exp Immunol. 1979 May;36(2):227-36. Clin Exp Immunol. 1979. PMID: 314367 Free PMC article.
-
Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients.Dev Biol Stand. 1977 Apr 13-15;38:449-53. Dev Biol Stand. 1977. PMID: 608536
-
Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations.Clin Exp Immunol. 1979 Jun;36(3):456-64. Clin Exp Immunol. 1979. PMID: 487647 Free PMC article.
-
Cancer immunotherapy: an overview.Semin Oncol. 1974 Dec;1(4):297-310. Semin Oncol. 1974. PMID: 4620437 Review. No abstract available.
-
Immunologic approaches to the management of ovarian carcinoma.Semin Oncol. 1984 Sep;11(3):264-74. Semin Oncol. 1984. PMID: 6207593 Review. No abstract available.
Cited by
-
Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity reactions.Clin Exp Immunol. 1979 May;36(2):227-36. Clin Exp Immunol. 1979. PMID: 314367 Free PMC article.
-
Natural killer cells in human solid tumors.Cancer Metastasis Rev. 1983;2(4):337-50. doi: 10.1007/BF00048566. Cancer Metastasis Rev. 1983. PMID: 6203638 Review.
-
Adjuvant immune stimulation with Corynebacterium parvum during maintenance chemotherapy of acute myeloid leukemia. A prospective randomized study.Cancer Immunol Immunother. 1983;16(2):88-92. doi: 10.1007/BF00199237. Cancer Immunol Immunother. 1983. PMID: 6420046 Free PMC article.
-
Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity.J Clin Immunol. 1981 Jan;1(1):51-63. doi: 10.1007/BF00915477. J Clin Immunol. 1981. PMID: 7334070
-
Decreased monocyte antibody-dependent cell-mediated toxicity in stage I-II malignant melanoma. Augmentation by subcutaneous Corynebacterium parvum.Cancer Immunol Immunother. 1984;17(1):66-8. doi: 10.1007/BF00205500. Cancer Immunol Immunother. 1984. PMID: 6563946 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources